Cytokinetics Inc

Type: Company
Name: Cytokinetics Inc
Nationality: United States
Web Address: http://www.cytokinetics.com/
First reported May 16 2013 - Updated May 16 2013 - 1 reports
NewLink Genetics Corp
NewLink Genetics Corp

Cytokinetics to Hold Annual Meeting of Stockholders

Mobivity Announces First Quarter 2013 Financial Results; Provides Business Update May 16, 2013SocialWhirled Social Business Platform, and Company CEO, Honored By Network Products Guide Awards May 15, 2013George P Johnson (GPJ) India Wins Gold at WOW ... [Published AndhraNews.net - May 16 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Cytokinetics to Hold Annual Meeting of Stockholders (Cytokinetics, Inc.)

- Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2013 at 1:30 PM Pacific Time at the Embassy Suites Hotel, located at 250 Gateway Boulevard in South San Francisco, CA. ... [Published Presscontacts.com - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Cytokinetics, Inc.: Cytokinetics to Hold Annual Meeting of Stockholders

- Cytokinetics, Incorporated (Nasdaq: CYTK (http://finance.yahoo.com/q's=rnvs&d=t)) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2013 at 1:30 PM Pacific Time at the Embassy Suites Hotel, located at 250 Gateway ... [Published FinanzNachrichten.de - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports
Cytokinetics Inc
Cytokinetics Inc

Cytokinetics to Hold Annual Meeting of Stockhol...

- Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2013 at 1:30 PM Pacific Time at the Embassy Suites Hotel, located at 250 Gateway Boulevard in South San Francisco, CA. ... [Published Best Invest - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports
Phase II
Phase II

Cytokinetics to Hold Annual Meeting of Stockholders

- Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2013 at 1:30 PM Pacific Time at the Embassy Suites Hotel, located at 250 Gateway Boulevard in South San Francisco, CA. ... [Published ACN Newswire - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports
PennyMac Mortgage Investment Trust
PennyMac Mortgage Investment Trust

Stocks to Watch (Cytokinetics, Companhia Siderurgica Nacional, PennyMac Mortgage Investment Trust, Research in Motion Ltd)

Austin, TX -- (SBWIRE) -- 05/15/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-Cytokinetics, ... [Published SBWire - May 15 2013]
First reported May 13 2013 - Updated May 13 2013 - 1 reports

"Cytokinetics, Incorporated - Product Pipeline Review - 2013" is now available at Fast Market Research

(live-PR.com) - Global Market Direct's pharmaceuticals report, "Cytokinetics, Incorporated - Product Pipeline Review - 2013" provides data on the Cytokinetics, Incorporated's research and development focus. The report includes information on current developmental ... [Published Live-PR.com - May 13 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

Cytokinetics Q1 net loss increases

Cytokinetics, Incorporated, a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $12.62 million, or $0.09 loss per share, compared to a net loss of $9.93 million, or $0.13 loss per share, for the same ... [Published Individual.com - May 09 2013]
First reported May 07 2013 - Updated May 08 2013 - 2 reports

Stock Losers: Novavax, Vitamin Shoppe Inc, North American Palladium Ltd, Cytokinetics

Dallas, TX -- (SBWIRE) -- 05/08/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-Novavax, Inc. (NASDAQ:NVAX) shares ... [Published SBWire - May 08 2013]
First reported Apr 30 2013 - Updated Apr 30 2013 - 4 reports

Cytokinetics, Inc. : Cytokinetics, Incorporated Reports First Quarte...

Company Elaborates on Key Progress in Cardiac and Skeletal Muscle ProgramsSOUTH SAN FRANCISCO, CA, April 30, 2013- Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues of $0.8 million for the first quarter of 2013. ... [Published Investegate - Apr 30 2013]
First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results

Company Elaborates on Key Progress in Cardiac and Skeletal Muscle ProgramsSOUTH SAN FRANCISCO, CA, April 30, 2013 - Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues of $0.8 million for the first quarter of 2013. ... [Published Reuters - Apr 30 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 2 reports

REVOLUTION LIGHTING TECHNOLOGIES INC: News And Commentary On High Volume Stocks: (NASDAQ: RVLT), (NASDAQ: CYTK)

New York (April 22nd, 2013) - Revolution Lighting Technologies, Inc.?s (NASDAQ: RVLT) CEO and chairman, Robert V. LaPenta, addressed the company's plans for continued expansion and development in 2013. Revolution Lighting Technologies designs, manufactures ... [Published 4 Traders - Apr 22 2013]

Quotes

...able to reverse the underlying disease pathology and clear amyloid deposits," said Andrew I McDonald, Ph D , Founding Partner at LifeSci Advisors. "Prothena's NEOD001 development candidate has the potential to be the first disease modifying therapy for amyloidosis that actually helps patients recover from the disease, rather than just slowing their decline."
LifeSci Advisors Initiates Coverage of Prothena Corporation Marketwired [Published Yahoo! Finance - May 15 2013]
...through important milestones in both of our later-stage clinical development programs," stated Robert I Blum, Cytokinetics President and CEO. "We recently announced the completion of enrollment in ATOMIC-AHF, our Phase IIb trial evaluating an intravenous form of omecamtiv mecarbil in acute heart failure patients, and the initiation of dosing in COSMIC-HF, our Phase II trial evaluating oral forms of omecamtiv mecarbil in outpatients with heart failure. In addition, during the last quarter, BENEFIT-ALS, our Phase IIb clinical trial evaluating tirasemtiv in patients with ALS, exceeded 200 patients enrolled, and we initiated Phase I dosing of CK-2127107, our second fast skeletal muscle troponin activator. We believe Cytokinetics is executing well on our key milestones for 2013 and we are looking forward to Phase IIb clinical trial results from each of ATOMIC-AHF and BENEFIT-ALS."
Cytokinetics Q1 net loss increases [Published Individual.com - May 09 2013]
...to grow, but all of the available treatment options suffer from drawbacks," said Andrew I McDonald, Ph D , Founding Partner at LifeSci Advisors. "A safe and effective oral testosterone product has the potential to quickly take market share from existing products, and also to expand the overall market by bringing in patients who aren't comfortable with current products."
LifeSci Advisors Initiates Coverage of Lipocine Inc. [Published Individual.com - May 07 2013]
...a great need for new therapies to address the underlying disease pathology," said Andrew I McDonald, Ph D , Founding Partner at LifeSci Advisors. "BrainStorm has presented promising early safety and efficacy data for their NurOwn(TM) stem cellcell therapy, which delivers neurotrophic factors directly to the patient's compromised nervous system, and this may prove to be a revolutionary treatment for ALS."
LifeSci Advisors Initiates Coverage of Brainstorm Cell Therapeutics [Published Individual.com - Apr 30 2013]

More Content

All (72) | News (52) | Reports (9) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Amgen, Inc. Management Presents at UBS Global H... [Published Seeking Alpha - 22 hours ago]
SADIF Analytics releases new rating update repo... [Published PR inside - May 21 2013]
Cytokinetics to Hold Annual Meeting of Stockhol... [Published AndhraNews.net - May 16 2013]
Cytokinetics to Hold Annual Meeting of Stockhol... [Published Presscontacts.com - May 15 2013]
Cytokinetics, Inc.: Cytokinetics to Hold Annual... [Published FinanzNachrichten.de - May 15 2013]
Cytokinetics to Hold Annual Meeting of Stockhol... [Published Best Invest - May 15 2013]
Cytokinetics to Hold Annual Meeting of Stockhol... [Published ACN Newswire - May 15 2013]
Stocks to Watch (Cytokinetics, Companhia Sideru... [Published SBWire - May 15 2013]
LifeSci Advisors Initiates Coverage of Prothena... [Published Yahoo! Finance - May 15 2013]
SmithOnStocks Opines On Recent Biotech News [Published Seeking Alpha - May 13 2013]
"Cytokinetics, Incorporated - Product Pipeline ... [Published Live-PR.com - May 13 2013]
Cytokinetics Q1 net loss increases [Published Individual.com - May 09 2013]
News Recap: TravelCenters of America, Quicksilv... [Published SBWire - May 08 2013]
Stock Losers: Novavax, Vitamin Shoppe Inc, Nort... [Published SBWire - May 08 2013]
Stock Losers: Cytokinetics, Sanofi SA, Golden S... [Published SBWire - May 07 2013]
LifeSci Advisors Initiates Coverage of Lipocine... [Published Individual.com - May 07 2013]
Cytokinetics, Incorporated Reports First Quarte... [Published AndhraNews.net - May 01 2013]
Cytokinetics' CEO Discusses Q1 2013 Results - E... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 30 2013]
Cytokinetics, Inc. : Cytokinetics, Incorporated... [Published Investegate - Apr 30 2013]
Cytokinetics, Incorporated Reports First Quarte... [Published Reuters - Apr 30 2013]
Cytokinetics, Incorporated Reports First Quarte... [Published Yahoo! Finance - Apr 30 2013]
Cytokinetics, Inc.: Cytokinetics, Incorporated ... [Published FinanzNachrichten.de - Apr 30 2013]
Cytokinetics, Incorporated Reports First Quarte... [Published Individual.com - Apr 30 2013]
LifeSci Advisors Initiates Coverage of Brainsto... [Published Live-PR.com - Apr 30 2013]
LifeSci Advisors Initiates Coverage of Brainsto... [Published Individual.com - Apr 30 2013]
Stocks Buzz: MBIA Inc. (NYSE:MBI), Joe's Jeans ... [Published SBWire - Apr 30 2013]
Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Cy... [Published SBWire - Apr 29 2013]
GTx, Inc.: Is This Microcap Breaking Out? [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 25 2013]
Reply – Weighing in on Congestion [Published Journal of the American College of Cardiology - Apr 25 2013]
Gainers List: Power One Inc. (NASDAQ:PWER), Nat... [Published SBWire - Apr 23 2013]
1 2 3
In Focus
  •  
Robert I. Blum, Charles Duncan, Jason Butler, [more]
  •  
Amgen Inc, New York Stock Exchange, Catalyst Pharmaceutical Partners Inc, [more]
  •  
European Medicines Agency, FDA Food & Drug Administration, US Securities and Exchange Commission, [more]
  •  
Drugs, Clinical trials, Amyotrophic Lateral Sclerosis, [more]
  •  
Hexyon, S&P 500, Desloratadine, [more]
  •  
South San Francisco (United States), San Francisco (United States), Dallas (Texas, United States), [more]
  •  
United States, Canada, Japan, [more]
  •  
Diseases, Narcotics, Medication, [more]
  •  
Real Estate, Telecom, Utilities, [more]
SBWire, Individual.com, FinanzNachrichten.de, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
InPlay from Briefing.com [Published MaritimeSecurity.Asia - Feb 13 2013]
7:02 pm Limoneira announces the annexation of East Area 1 into the city of Santa Paula ( LMNR ) : Co announced that on February 12, 2013, East Area 1 was formally annexed into Santa Paula. The annexation was the final required step to enable Limoneira ...
4 Healthcare Stock Stories for Monday Wellness [Published Wall St. Cheat Sheet - Jan 28 2013]
Cytokinetics, Incorporated ( NASDAQ:CYTK ): Current price $1.07 On Thursday, the firm received a notice from Nasdaq confirming that for the last 10 consecutive business days, the closing bid price of the Company’s common stock has been at $1 per share ...
Monsanto Gains Market Share and 4 Stock Analyse... [Published Wall St. Cheat Sheet - Dec 13 2012]
Energizer Holdings Inc. ( NYSE:ENR ) growth is believed by RBC Capital believes that Energizer’s growth to begin accelerating during 2Q13, and the firm is convinced that the company’s annual EPS growth may potentially rise to 10 percent over the next ...
GlaxoSmithKline Raises Stakes in India & Nigeri... [Published Wall St. Cheat Sheet - Nov 26 2012]
The United Kingdom’s largest drug maker , GlaxoSmithKline ( NYSE:GSK ), intends to shell out more than $1 billion so as to raise stakes in its Indian and Nigerian consumer healthcare units, to broaden its presence in emerging markets and non-prescription ...
1

Press Releases

sort by: Date | Relevance
SADIF Analytics releases new rating update repo... [Published PR inside - May 21 2013]
Research and Markets: Peripheral Arterial Disea... [Published Business Wire - Apr 17 2013]
The Zacks Analyst Blog Highlights:Elan, Biogen ... [Published Financial Services - Apr 04 2013]
U.S. Food and Drug Administration Approved 30% ... [Published Marketwire - Breaking News Releases - Feb 15 2013]
Research and Markets: Cytokinetics' CK-2017357 ... [Published Business Wire Science: Science News - Jan 04 2013]
1 2
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.